Conclusion
Laboratory testing and vaccination have played a crucial role in the prevention and control of brucellosis worldwide. Still, laboratory-acquired infection and vaccination-related infection events are worthy of attention. With the development of molecular biology techniques and a deep understanding of the pathogenic mechanism ofBrucella , new vaccines based on genome engineering are expected to replace traditional vaccines for brucellosis control. This report serves as a reminder that occupational Brucella exposure is a risk among clinical laboratory staff and veterinary personnel. Clinicians, laboratory staff members, and public health officials should be aware of diagnosis and treatment challenges of occupational brucellosis and be prepared to manage brucellosis occupational exposures and improve the awareness of brucellosis in high-risk populations. Only the implementation of these measures will eliminate this occupational infection.